| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Jun―26 |
Therapeutic Plasma Exchange and Immunomodulatory Strategies in Post-Infectious Syndromes: A Review of Immune Dysregulation in PTLDS, Long COVID, ME/CFS, and PANS/PANDAS |
Gary Kaplan |
| 2 |
[GO] |
2026―Jan―30 |
A STEM CELL DONATION WITH A COVID-19 POSITIVE MATCHED UNRELATED DONOR |
M.M. Polisi, M. Bevini, D. Venturelli |
| 3 |
[GO] |
2025―Jul―15 |
Mitochondrial DNA levels in plasma products: A comparative study of apheresis plasma from COVID-19 convalescent donors and apheresis and fresh frozen plasma from non-infected donors |
Fatemeh Tavangar, Azita Chegini, Maryam Zadsar, Shahram Samiee |
| 4 |
[GO] |
2025―Jun―06 |
Incidence and predictors of hospital acquired anemia in COVID-19 ARDS patients hospitalized in intensive care unit |
Büşra Tezcan, Behiye Deniz Kosovalı, Müçteba Can, Ali Eba Demirbağ, Asiye Yavuz, Nevzat Mehmet Mutlu |
| 5 |
[GO] |
2025―Apr―25 |
Unveiling the Impact of the COVID-19 Pandemic on Blood Donation Patterns: A Greek Perspective |
Sotirios P. Fortis, Georgios Dryllis, Alkmini T. Anastasiadi, Vassilis L. Tzounakas, Olympia konstantakopoulou, Hara T. Georgatzakou, Efthymia G. Pavlou, Andreas G. Tsantes, Vasiliki Theodorogianni, Maria-Aspasia kosma, Effie G. Papageorgiou, Konstantinos E. Stamoulis, Apostolos Beloukas, Marianna Politou, Serena Valsami, Anastasios G. kriebardis |
| 6 |
[GO] |
2024―Oct―30 |
Editorial commentary: The latest viewpoint on a statistical analysis of total analytical errors in diagnostic tools used for quantitative testing of medical devices in transfusion medicine & insights on the development of autoantibody isotypes to the Annexin A1 protein of the neutrophil in association with COVID-19-induced hyperinflammatory processes |
Jerard Seghatchian |
| 7 |
[GO] |
2024―Oct―28 |
Laboratory Measurement of Autoantibodies to Annexin A1: review and measurements in health and COVID-19 |
Jean AMIRAL, Rémy FEROL, Matthias H. Busch, Sjoerd A.M.E.G. Timmermans, Chris Reutelingsperger, Pieter van Paassen |
| 8 |
[GO] |
2024―Apr―24 |
Determination of optimum levels of binding antibody units (BAU) of new quantitative chemiluminescent immuno-assay (CLIA) in COVID-19 vaccinated volunteer blood donors |
Aseem Kumar Tiwari, Geet Aggarwal, Pratibha Kale, Neeti Yadav, Virendra Kumar, Gargi Singh, K. Cheirmaraj, K. Krishnan |
| 9 |
[GO] |
2024―Mar―14 |
Can SARS-CoV-2 Infection Cause Prolonged Pseudothrombocytopenia? A Case Presentation and Literature Summary |
Unal Atas, Mustafa Sinanoglu, Volkan Karakus |
| 10 |
[GO] |
2023―Aug―12 |
Long-term antibody titers variation in unvaccinated patients receiving convalescent plasma or placebo for severe SARS-CoV-2 pulmonary infection. |
Paula Scibona, Leandro Daniel Burgos Pratx, Nadia Savoy, Delfina Recart, Yasmin Elia, Facundo Nahuel Seoane, Diego Arrigo, Maximo Rousseau Portalis, Agustina Roldan, Belen Amarilla Cassoratti, Julio Cesar Diaz, Camila Ernestina Antonelli, Lucia Perez, Lourdes Posadas-Martinez, Waldo H. Belloso, Ventura Simonovich |
| 11 |
[GO] |
2023―Jun―16 |
AUTOLOGOUS VERSUS ALLOGENEIC BLOOD TRANSFUSION: A COMPARATIVE STUDY OF THE PERI-OPERATIVE OUTCOMES IN A TERTIARY CARE HOSPITAL IN SOUTH INDIA AMIDST THE COVID-19 PANDEMIC |
Angel Mary Sam, Debasish Gupta, Amita Radhakrishnan, Manikandan Sethuraman, Prasanta Kumar Dash, Shivanesan Pitchai, Krishnakumar Kesavapisharady |
| 12 |
[GO] |
2023―May―08 |
Is there any revival of the use of plasma therapy or neutralizing convalescent antibody therapy to treat SARS-CoV-2 variants and are we rethinking preparedness plans? |
Olivier Garraud, Hervé Watier |
| 13 |
[GO] |
2023―Apr―13 |
A Case of Hyperhemolysis Syndrome in Sickle Cell Disease and Concomitant COVID-19 |
Allen Green, Heather Jones, Alecia Nero, Ibrahim F. Ibrahim, Ravi Sarode, Lisa M. Scheid, Christopher B. Webb, Brian D. Adkins, Sean G. Yates |
| 14 |
[GO] |
2023―Mar―29 |
Impact of Covid 19 pandemic on hematopoietic stem cell transplantation activities: report from a single center |
Sabrina Giammarco, Simona Sica, Elisabetta Metafuni, Maria Assunta Limongiello, Caterina Giovanna Valentini, Federica Sorà, John Donald Marra, Andrea Bacigalupo, Luciana Teofili, Patrizia Chiusolo |
| 15 |
[GO] |
2023―Mar―20 |
The safety of plasma apheresis from donors recovering from COVID-19 infection in Japan |
Ayumi Kamo-Imai, Tomiteru Togano, Motohiko Sato, Yuiko Kawakami, Kumi Inaba, Hiroshi Shimazu, Saori Igarashi, Keiko Tanaka, Mari Terada, Noriko Kinoshita-Iwamoto, Sho Saito, Satoshi Kutsuna, Akira Hangaishi, Shinichiro Morioka, Kenzo Takahashi, Satoshi Miyata, Norio Ohmagari |
| 16 |
[GO] |
2023―Mar―11 |
Effects of Cytokine Hemadsorption as Salvage Therapy on Common Laboratory Parameters in Patients with Life-threatening COVID-19 |
Serhat Uysal, Mustafa Merter, Ayşe Uysal, Ayhan Akbulut |
| 17 |
[GO] |
2023―Mar―04 |
Assessment of the impact of pathogen reduction technologies on the neutralizing activity of COVID-19 convalescent plasma. |
Salwa Hindawi, Tarek Elgemmezi, Sherif El-Kafrawi, Hani Samadani, Myasin Tilmisani, Omar Assiri, Mohammad Raml, Esam Azhar, Maha Badawi |
| 18 |
[GO] |
2023―Feb―25 |
Nurses perspective of apheresis in SARS-CoV-2 infected patients |
Linda Tjoelker en Hans Vrielink |
| 19 |
[GO] |
2023―Jan―31 |
POLYCLONAL IMMUNOGLOBULINS FOR COVID-19 PRE-EXPOSURE PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS |
Daniele Focosi, Massimo Franchini |
| 20 |
[GO] |
2022―Dec―29 |
Preserved SARS-CoV-2 neutralizing IgG activity of in-house manufactured COVID-19 convalescent plasma |
Makoto Inada, Tomiteru Togano, Mari Terada, Katsuyuki Shiratori, Shinya Tsuzuki, Yuki Takamatsu, Sho Saito, Akira Hangaishi, Shinichiro Morioka, Satoshi Kutsuna, Kenji Maeda, Hiroaki Mitsuya, Norio Ohmagari |
| 21 |
[GO] |
2022―Dec―17 |
Autoimmune complications of COVID-19 and potential consequences for long-lasting disease syndromes |
Jean AMIRAL, Jerard Seghatchian |
| 22 |
[GO] |
2022―Nov―03 |
Apheresis and COVID-19 |
Xanthi Zikou, Vasiliki Polychronidou, Stavros Aloizos |
| 23 |
[GO] |
2022―Nov―01 |
IMMUNOADSORPTION AND COVID 19 PANDEMIC |
Paraskevi Tseke, Ioannis Griveas |
| 24 |
[GO] |
2022―Nov―01 |
Apheresis and COVID-19 in intensive care unit (ICU) |
Zikou Xanthi, Polychronidou Vasiliki, Aloizos Stavros |
| 25 |
[GO] |
2022―Oct―28 |
Effectiveness of Hemoperfusion (HP) in hemodialysis (HD) patients with Covid-19 infection |
Ioannis Griveas |
| 26 |
[GO] |
2022―Oct―28 |
Soluble Urokinase Plasminogen Activator Receptor and its complicated role in hemodialysis (HD) patients with Covid-19 infection |
Ioannis Griveas, Evaggelos Pratilas |
| 27 |
[GO] |
2022―Sep―12 |
Acquired hemophilia A following COVID-19 vaccination - The importance of prompt diagnosis: A case report |
Andrea Duminuco, Marianna Calagna, Uros Markovic, Benedetta Esposito, Stephanie Grasso, Carla Riccobene, Francesco Di Raimondo, Gaetano Giuffrida |
| 28 |
[GO] |
2022―Sep―06 |
Exploring the unseen effect of COVID 19 pandemic on blood transfusion services in a tertiary care centre |
Paramjit Kaur, Ravneet Kaur Bedi, Kshitija Mittal, Tanvi Sood |
| 29 |
[GO] |
2022―Aug―30 |
Screening for antibodies to HLA class I in apheresis donors following Covid-19 or SARS-CoV-2 vaccination |
Lise Sofie H Nissen-Meyer, Elzbieta Czapp, Christian Naper, Tore Jensen, Line M L Boulland |
| 30 |
[GO] |
2022―Aug―26 |
Analysis of the IgG subclass profile and IgG sum-total discrepancy in COVID-19 convalescent plasma donors: A single-centre prospective cohort study |
Tomasz Wasiluk, Magdalena Sredzinska, Anna Rogowska, Agnieszka Zebrowska, Barbara Boczkowska-Radziwon, Anna Stasiak-Barmuta, Piotr Radziwon |
| 31 |
[GO] |
2022―Aug―04 |
Rethinking the role of COVID-19 convalescent plasma in the critically ill |
Arturo Casadevall, Liise-anne Pirofski |
| 32 |
[GO] |
2022―Jul―01 |
CONVALESCENT PLASMA- AN INSIGHT INTO A NOVEL TREATMENT OF COVID-19 ICU PATIENTS |
Mohit Chowdhry, Maryam Hussain, Prachi Singh, Minu Lekshmi, Soma Agrawal, MS Kanwar, Rajesh Chawla, Viny Kantroo, Roseleen Bali, Avdesh Bansal, Aakanksha Chawla, Nikhil Modi, Manoj Mishra, Zaigham Khan |
| 33 |
[GO] |
2022―Jun―14 |
SARS-CoV-2 and Cancer: The intriguing and informative cross-talk |
Hadi Goubran, Julie Stakiw, Jerard Seghatchian, Gaafar Ragab, Thierry Burnouf |
| 34 |
[GO] |
2022―Jun―11 |
COVID-19 convalescent plasma: current status, lessons from the past and future perspectives |
Tor Audun Hervig, Øystein Flesland, Lise Sofie Haug Nissen-Meyer |
| 35 |
[GO] |
2022―Jun―11 |
Can plasma exchange therapy be an option for the treatment of SARS-CoV-2 Related Splenial Lesion Syndrome: Two cases from the pediatric intensive care unit |
Fatih Varol, Nese Ergul, Ebru Guney Sahin, Yasar Yusuf Can, Umut Ergul, Sirin Guven, Halit Cam |
| 36 |
[GO] |
2022―May―21 |
Platelet and extracellular vesicles in COVID-19 infection and its vaccines |
Hadi Goubran, Jerard Seghatchian, Waleed Sabry, Gaafar Ragab, Thierry Burnouf |
| 37 |
[GO] |
2022―May―11 |
Effect of Convalescent Plasma therapy on Mortality in Moderate-to-Severely Ill COVID-19 Patients |
Akanksha Agrawal, Tanvi Jha, Priyanka Gogoi, Preeti Diwaker, Ashish Goel, Amir Maroof Khan, Ashok Kumar Saxena |
| 38 |
[GO] |
2022―May―10 |
Human Placenta-derived Mesenchymal Stromal Cells Transfusion in a Critically Ill Infant Diagnosed with Coronavirus Disease 2019 (COVID-19): A Case Report |
Mehrdad Payandeh, Reza Habibi, Amir Hossein Norooznezhad, Zohreh Hoseinkhani, Feizollah Mansouri, Reza Yarani, Avnesh S. Thakor, Mitra Bakhtiari, Farzaneh Esmailli, Kamran Mansouri |
| 39 |
[GO] |
2022―Apr―11 |
ABO and Rh blood groups, demographics, and comorbidities in COVID-19 related deaths: A retrospective study in Split-Dalmatia County, Croatia |
Ivan Brdar, Ivan Jerković, Željana Bašić, Nenad Kunac, Deny Anđelinović, Joško Bezić, Ivana Kružić, Arijana Vuko, Šimun Anđelinović |
| 40 |
[GO] |
2022―Apr―09 |
Is SARS-CoV-2 screening still necessary before hematopoietic stem cell donation? Observations from a single center and review of the literature |
Roberto Crocchiolo, Elisabetta Volpato, Laura Bellio, Irene Cuppari, Gabriele Magliano, Beatrice De Marco, Giovanni Grillo, Silvano Rossini |
| 41 |
[GO] |
2022―Apr―01 |
Impact of COVID-19 on the efficacy of meeting the transfusion demand by a Brazilian blood banks network |
Daniela de Oliveira Werneck Rodrigues, Nathalia Noyma Sampaio Magalhães, Maria Clara Fernandes Silva-Malta, Daniel Gonçalves Chaves, Ricardo Villas Freire de Carvalho, Maisa Aparecida Ribeiro, Júnia Guimarães Mourão Cioffi, Marina Lobato Martins |
| 42 |
[GO] |
2022―Mar―23 |
Role of therapeutic plasma exchange in the management of COVID-19-induced cytokine storm syndrome |
Mickael Beraud, Sabria Al Hashami, Miquel Lozano, Aicha Bah, Philip Keith |
| 43 |
[GO] |
2022―Mar―15 |
The feasibility of multiple units of convalescent plasma in mechanically ventilated patients with COVID-19: A pilot study |
Noah M. Merin, Alexis A. LeVee, Christian A. Merlo, Kellie Spector, Hannah Coleman, Ellen Klapper, Chelsea Hayes, Rachel Zabner, John F. McDyer, Yolanda J. Eby, David J. Sullivan, Aaron A.R. Tobian, Evan M. Bloch, David N. Hager |
| 44 |
[GO] |
2022―Mar―12 |
Angiotensin (1-7) peptide replacement therapy with plasma transfusion in COVID-19 |
Hasan Onal, Nurcan Ucuncu Ergun, Bengu Arslan, Seyma Topuz, Seda Yilmaz Semerci, Osman Mutluhan Ugurel, Murat Topuzogullari, Ali Kalkan, Sengul Aydin Yoldemir, Nurettin Suner, Ali Kocatas |
| 45 |
[GO] |
2022―Mar―05 |
Using Automation to Manage Donor Engagement and Fine-Tune Supply and Demand During the First Year of the COVID-19 Pandemic |
Theresa Pina, Marc Lewis, Charity Garrison, Anna Razatos |
| 46 |
[GO] |
2022―Feb―16 |
SARS-CoV-2 variants inactivation of plasma units using a riboflavin and ultraviolet light-based photochemical treatment |
Alessandro Ferrari, Irene Cassaniti, Josè Camilla Sammartino, Cristina Mortellaro, Claudia Del Fante, Simona De Vitis, Eugenio Barone, Daniela Troletti, Federica Prati, Fausto Baldanti, Elena Percivalle, Perotti Cesare |
| 47 |
[GO] |
2022―Jan―31 |
Seroprevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Campeche Mexico |
Victor Monteón, Floribeth Leon Pérez, Virginia Peña Hernández, Anatalia Osorio Pacheco, Pedro Fuentes Guzman, Gicel Ivett Gutiérrez Torres |
| 48 |
[GO] |
2022―Jan―17 |
Role of the AB0 blood group in COVID-19 infection and complications: A population-based study |
Mónica Enguita-Germán, Julián Librero, Leire Leache, Marta Gutiérrez-Valencia, Ibai Tamayo, Carlos Jericó, Javier Gorricho, José Antonio García-Erce |
| 49 |
[GO] |
2022―Jan―13 |
Lessons learned from the use of convalescent plasma for the treatment of COVID-19 and specific considerations for immunocompromised patients |
Mickael Beraud, Erin Goodhue Meyer, Miquel Lozano, Aicha Bah, Ralph Vassallo, Bethany L. Brown |
| 50 |
[GO] |
2022―Jan―13 |
The impact of blood campaigns using mobile blood collection drives on blood supply management during the COVID-19 pandemic |
Amr J. Halawani |
| 51 |
[GO] |
2021―Dec―08 |
COVID-19-associated Evans syndrome: A case report and review of the literature |
Atakan Turgutkaya, Ali Zahit Bolaman, İrfan Yavaşoğlu |
| 52 |
[GO] |
2021―Dec―06 |
Seroprevalence of SARS-CoV-2 IgG antibody among healthy blood donors: a single centre study |
Ram Jaiswal, Shweta Sharma, Ashina Singla, Nimisha Devpura, Rajat Vohra, Munish Kakkar, Puneet Rijhwani, Rajendra Sureka |
| 53 |
[GO] |
2021―Nov―24 |
Early high-titer convalescent plasma therapy in patients with moderate and severe COVID-19 |
Alieh Fazeli, Shahin Sharifi, Fatemeh Behdad, Shamsi Okati, Gilda Esmaielifar, Nooshin Jelveh, Peyman Eshghi, Saeed Mohammadi |
| 54 |
[GO] |
2021―Nov―23 |
SARS-CoV-2 antibody changes in patients receiving COVID-19 convalescent plasma from normal and vaccinated donors |
Judith Leon, Anna E. Merrill, Kai Rogers, Julie Kurt, Spencer Dempewolf, Alexandra Ehlers, J. Brooks Jackson, C. Michael Knudson |
| 55 |
[GO] |
2021―Oct―29 |
The demographic and serological characteristics of COVID-19 convalescent plasma donors: Identification of basic criteria for optimal donor selection |
Alieh Fazeli, Shahin Sharifi, Saeed Mohammadi, Mehran Bahraini, Ali Arabkhazaeli, Nooshin Jelveh, Peyman Eshghi |
| 56 |
[GO] |
2021―Oct―22 |
Blood shortages and changes to massive transfusion protocols: Survey of hospital practices during the COVID-19 pandemic |
Jeremy W. Jacobs, Garrett S. Booth |
| 57 |
[GO] |
2021―Oct―16 |
Acute pancreatitis due to severe hypertriglyceridemia in the COVID-19 era: the role of Therapeutic Plasma Exchange |
Francesca Pavanello, Anna Colpo, Tiziana Tison, Roberto Fabris, Giustina De Silvestro, Piero Marson |
| 58 |
[GO] |
2021―Sep―21 |
Implementation of Maximum Surgical Blood Ordering Schedule in A Tertiary Hospital in Malaysia during COVID-19 Pandemic |
Tan Pei Pei, Jernih Abdul Rahman, Sarah Mat Noh, Irni Mohd Yasin, Sabariah Mohd Noor |
| 59 |
[GO] |
2021―Sep―17 |
Convalescent plasma therapy in B-cell-depleted and B-cell sufficient patients with life-threatening COVID-19 - a case series |
Johanna Erber, Johannes R. Wiessner, Christina Huberle, Jochen Schneider, Hrvoje Mijočević, Doris von Bomhard, Peter Luppa, Roland M. Schmid, Sebastian Rasch, Tobias Lahmer |
| 60 |
[GO] |
2021―Aug―17 |
Sero-prevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Norway, winter/spring 2021 |
Marte Hvalryg, Lise Sofie H. Nissen-Meyer |
| 61 |
[GO] |
2021―Aug―17 |
Mesenchymal stem cell transfusion: Possible beneficial effects in COVID-19 patients |
Tuğçe Nur Yiğenoğlu, Semih Başcı, Derya Şahin, Turgay Ulaş, Mehmet Sinan Dal, Serdal Korkmaz, Tuba Hacıbekiroğlu, Sinem Namdaroğlu, Mehmet Ali Erkurt, Burhan Turgut, Fevzi Altuntaş |
| 62 |
[GO] |
2021―Aug―10 |
SHOULD TIMING BE CONSIDERED BEFORE ABANDONING CONVALESCENT PLASMA IN COVID-19? RESULTS FROM THE TURKISH EXPERIENCE |
İhsan Ateş, Abdulsamet Erden, Serdar Can Güven, Elif Kübra Gürler, Adem Çağlayan, Özge Güçbey, Hakan Apaydın, Enes Seyda Şahiner, Hamit Küçük, Özkan Varan, Ahmet Omma, Orhan Küçükşahin |
| 63 |
[GO] |
2021―Jul―30 |
The association of ABO blood group with the asymptomatic COVID-19 cases in India |
Prajjval Pratap Singh, Abhishek K. Srivastava, Sudhir K. Upadhyay, Ashish Singh, Shashank Upadhyay, Pradeep Kumar, Vandana Rai, Pankaj Shrivastava, Gyaneshwer Chaubey |
| 64 |
[GO] |
2021―Jul―06 |
Awareness about Coronavirus (COVID-19) and challenges for blood services among potential blood donors |
Saud Almalki, Mohamed Asseri, Yahya Khawaji, Riad Alqurashi, Maha Badawi, Nehal Yakout, Tarek Elgemmezi, Salwa Hindawi |
| 65 |
[GO] |
2021―Jun―26 |
A case of psoriasis successfully treated by extracorporeal photopheresis during COVID-19 pandemic |
Pelin Esme, Semanur Coban, Bilge Ugur, Meltem Aylı, Ercan Caliskan |
| 66 |
[GO] |
2021―Jun―15 |
COVID-19 antibody donation using immunoadsorption: Report of two cases |
Jannik Rothenburg, Silke Rink-Baron, Lisa Mueller, Philipp Niklas Ostermann, Johannes Fischer, Johannes Stegbauer, Anja Moldenhauer |
| 67 |
[GO] |
2021―Jun―10 |
Ubiquitous Convalescent Plasma: An Artificial Universal Plasma for COVID-19 Patients |
Mahla Sattarzadeh Bardsiri, Seyedeh Mehrnaz Kouhbananinejad, Reza Vahidi, Saeed Soleimany, Masoud Moghadari, Ali Derakhshani, Bahareh Kashani, Alireza Farsinejad |
| 68 |
[GO] |
2021―Jun―03 |
Sequential Dosing of Convalescent COVID-19 Plasma with Significant Temporal Clinical Improvements in a Persistently SARS-COV-2 positive Patient |
Noupama Mirihagalle, Priyanka Parajuli, Vidya Sundareshan, Debadoot Saha, Arpan Shah, Francine Chua, Sana Waqar, Vidhya Prakash, Aaron A.R. Tobian, Evan M. Bloch, Louis Katz, Ruchika Goel |
| 69 |
[GO] |
2021―Jun―03 |
Blood donor deferral periods after COVID-19 vaccination |
Abhaykumar Malind Gupta |
| 70 |
[GO] |
2021―May―26 |
Use Of Face Mask By Blood Donors During The Covid 19 Pandemic: Impact On Donor Hemoglobin Concentration: A Bane Or A Boon |
Rasika Setia, Mitu Dogra, Anil Handoo, Ramesh Yadav, Gokhula Prasath Thangavel, Amena Ebadur Rahman |
| 71 |
[GO] |
2021―May―23 |
Commentary: Convalescent plasma to treat COVID-19: Following the Argentinian lead |
Pierre Tiberghien, Eric Toussirot, Pascale Richard, Pascal Morel, Olivier Garraud |
| 72 |
[GO] |
2021―May―21 |
Systematic Review and Meta-analysis of the Susceptibility of ABO Blood Group to COVID-19 Infection |
Saeed M Kabrah, Ahmad Kabrah, Arwa F Flemban, Samer Abuzerr |
| 73 |
[GO] |
2021―May―08 |
Efficacy of Convalescent Plasma Therapy in Severe COVID-19 Patients |
Hilal Akay Cizmecioglu, Mevlut Hakan Goktepe, Sinan Demircioglu, Atakan Tekinalp, Ahmet Cizmecioglu, Ali Kursat Tuna, Huseyin Ozer |
| 74 |
[GO] |
2021―Apr―24 |
Effects On Mortality Of Early Vs Late Administration Of Convalescent Plasma In The Treatment Of Covid-19 |
Havva Kocayiğit, Gürkan Demir, Alper Karacan, Kezban Özmen Süner, Yakup Tomak, Selçuk Yaylacı, Hamad Dheir, Yasin Kalpakci, Ali Fuat Erdem |
| 75 |
[GO] |
2021―Apr―20 |
Plasma exchange followed by convalescent plasma transfusion in COVID-19 patients |
Elham Roshandel, Ghazaleh Sankanian, Maryam Salimi, Arsalan Jalili, Sina Salari, Amir Sadeghi, Seyed Mohammadreza Hashemian, Mohammad Reza Moshari, Ali Pirsalehi, Abbas Hajifathali |
| 76 |
[GO] |
2021―Apr―19 |
Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine |
Cinzia Sissa, Ahmad Al-Khaffaf, Francesco Frattini, Roberta Gaiardoni, Elda Mimiola, Paolo Montorsi, Barbara Melara, Massimo Amato, Flora Peyvandi, Massimo Franchini |
| 77 |
[GO] |
2021―Apr―16 |
Survey based cross-sectional study to analyse the variation of practices at blood centres during COVID-19 pandemic in India |
Abhishekh Basavarajegowda, Meenu Bajpai, Satyam Arora, Ashish Maheshwari, Seema Dua, Dibyajyoti Sahoo |
| 78 |
[GO] |
2021―Apr―03 |
COVID-19 related callback in blood donors; outcomes in blood donors and patients |
Sahar Balagholi, Mahtab Maghsudlu, Sedigheh Amini-Kafiabad, Amir Masoud Nazemi, Maryam Sotoudeh Anvari |
| 79 |
[GO] |
2021―Mar―02 |
Convalescent Blood Plasma (CBP) Donated by Recovered COVID-19 Patients - A comment |
Th. Lung, B. Sakem, M. Risch, U. Nydegger |
| 80 |
[GO] |
2021―Feb―27 |
Treating Thrombotic Thrombocytopenic Purpura Without Plasma Exchange During the COVID-19 Pandemic. A Case Report and a Brief Literature Review |
César David Galindo-Calvillo, Carlos Saúl Rodríguez-Roque, Andrés Gómez-De León, Luz Tarín-Arzaga, David Gómez-Almaguer |
| 81 |
[GO] |
2021―Feb―21 |
TWO PATIENTS WITH RITUXIMAB ASSOCIATED LOW GAMMAGLOBULIN LEVELS AND RELAPSED COVID-19 INFECTIONS TREATED WITH CONVALESCENT PLASMA |
Irati Ormazabal Vélez, Juan Induráin Bermejo, José Espinoza Pérez, Laura Imaz Aguayo, Marina Delgado Ruiz, José Antonio García-Erce |
| 82 |
[GO] |
2021―Feb―21 |
Transfusion of blood products derived from SARS-CoV-2+ donors to patients with hematological malignancies |
Carlo Gambacorti-Passerini, Marco Ruggeri, Andrea Aroldi, Rocco Piazza, Angela Mazzi, Giustina De Silvestro, Mauro Krampera, Francesco Lanza |
| 83 |
[GO] |
2021―Feb―18 |
Changes in blood donation and utilization secondary to Covid-19 outbreak |
Carla L. Dinardo, Monica J. Vieira, Vanderson Rocha, Alfredo Mendrone-Júnior |
| 84 |
[GO] |
2021―Feb―17 |
The Story of an Extraordinary Year: Challenges and Opportunities in Responding to Covid-19 |
Lise Sofie H. Nissen-Meyer, Arne Broch Brantsæter |
| 85 |
[GO] |
2021―Feb―15 |
Immunotherapy for COVID-19: Evolving Treatment of Viral Infection and Associated Adverse Immunological Reactions |
Jeffrey S. Putter |
| 86 |
[GO] |
2021―Feb―10 |
People with blood disorders can be more vulnerable during COVID-19 pandemic: A Hypothesis Paper |
Duygu Aydemir, Nuriye Nuray Ulusu |
| 87 |
[GO] |
2021―Feb―05 |
Convalescent plasma therapy for severe Covid-19 in patients with hematological malignancies |
Preethi Jeyaraman, Narendra Agrawal, Rahul Bhargava, Divya Bansal, Rayaz Ahmed, Dinesh Bhurani, Sachin Bansal, Neha Rastogi, Pronamee Bora, Rahul Naithani |
| 88 |
[GO] |
2021―Jan―27 |
COVID-19 neutralizing antibody-based therapies in humoral immune deficiencies: A narrative review |
Daniele Focosi, Massimo Franchini |
| 89 |
[GO] |
2021―Jan―22 |
Iatrogenic anaemia and transfusion thresholds in ICU patients with COVID-19 disease at a tertiary care hospital |
Ivo Beverina, Erika Borotto, Chiara Novelli, Danilo Radrizzani, Bruno Brando |
| 90 |
[GO] |
2021―Jan―14 |
A Look-Back at Convalescent Plasma to Treat COVID-19 |
Olivier Garraud, Karine Lacombe, Pierre Tiberghien |
| 91 |
[GO] |
2021―Jan―14 |
New generation of vaccines and convalescent plasma therapy for management of CoV-2: Perspectives from the UK and potential deployment in the current global pandemic |
Jerard Seghatchian |
| 92 |
[GO] |
2021―Jan―14 |
New generation of vaccines and convalescent plasma therapy for management of CoV-2: Perspectives from the UK and potential deployment in the current global pandemic |
Jerard Seghatchian |
| 93 |
[GO] |
2021―Jan―02 |
Analysis of blood donors’ characteristics and deferrals related to COVID-19 in Iran |
Mohammad Hessam Rafiee, Sedigheh Amini Kafiabad, Mahtab Maghsudlu |
| 94 |
[GO] |
2020―Dec―23 |
THE USE OF CONVALESCENT PLASMA FOR PEDIATRIC PATIENTS WITH SARS-COV-2: A SYSTEMATIC LITERATURE REVIEW |
Marco Zaffanello, Giorgio Piacentini, Luana Nosetti, Massimo Franchini |
| 95 |
[GO] |
2020―Nov―26 |
Transfusion practices during the COVID-19 pandemic: an experience from a hematology daycare in India |
Jayastu Senapati, Mukul Aggarwal, Liji Louis, Salim Mirza, Pradeep Kumar, Rishi Dhawan, Jasmita Dass, Ganesh K. Vishwanathan, Hem Chandra Pandey, Poonam Coshic, Seema Tyagi, Tulika Seth, Manoranjan Mahapatra |
| 96 |
[GO] |
2020―Nov―24 |
Taking on a pandemic's challenge: Emergent solutions from a single Hemophlia treatment center in North India |
Nita Radhakrishnan, Ravi Shankar, Savitri Singh, Megha Rana |
| 97 |
[GO] |
2020―Nov―20 |
Convalescent plasma therapy in patients with COVID-19 |
Fevzi Altuntas, Tugce Nur Yigenoglu, Semih Bascı, Mehmet Sinan Dal, Serdal Korkmaz, Burhan Turgut, Mehmet Ali Erkurt |
| 98 |
[GO] |
2020―Nov―19 |
Convalescent Plasma (CP) Therapy in Patients with COVID-19 |
Banu Cakir |
| 99 |
[GO] |
2020―Nov―05 |
A patient affected by critical COVID-19 pneumonia, successfully treated with convalescent plasma |
Behzad Einollahi, Luca Cegolon, Hassan Abolghasemi, Sina Imanizadeh, Ali Bahramifar, Shi Zhao, Ramezan Jafari, Mohammad Javanbakht |
| 100 |
[GO] |
2020―Nov―02 |
Potential of Therapeutic Plasmapheresis in Treatment of COVID-19 Patients: Immunopathogenesis and Coagulopathy |
Sahar Balagholi, Rasul Dabbaghi, Peyman Eshghi, Seyed Asadollah Mousavi, Farhad Heshmati, Saeed Mohammadi |
| 101 |
[GO] |
2020―Nov―01 |
SARS-CoV-2 convalescent plasma therapy in pediatric patient after hematopoietic stem cell transplantation |
Dmitry Balashov, Pavel Trakhtman, Anna Livshits, Irina Kovalenko, Galina Tereshenko, Galina Solopova, Elena Petraikina, Alexei Maschan, Galina Novichkova |
| 102 |
[GO] |
2020―Oct―31 |
Blood supply management during the Covid-19 pandemic: Experience in a tertiary referral hospital in Malaysia |
Tan Pei Pei, Chang Chee Tao, Sabariah Mohd Noor |
| 103 |
[GO] |
2020―Oct―07 |
COVID-19: Further evidence of no transfusion transmission |
José Roberto Luzzi, Roberta Navarro, Carla Luana Dinardo |
| 104 |
[GO] |
2020―Sep―28 |
The effect of the COVID-19 pandemic on the adequacy of blood supply: Specialists in Transfusion Medicine need to establish models of preparedness |
Erasmia Rouka |
| 105 |
[GO] |
2020―Sep―25 |
Convalescent plasma to aid in recovery of COVID-19 pneumonia in a child with acute lymphoblastic leukemia |
Ravi Shankar, Nita Radhakrishnan, Seema Dua, Satyam Arora, Megha Rana, Dinesh Kumar Sahu, Sumit Rai, Devendra Kumar Gupta |
| 106 |
[GO] |
2020―Sep―20 |
Promoting access to COVID-19 convalescent plasma in low- and middle-income countries |
Evan M. Bloch, Ruchika Goel, Celina Montemayor, Claudia Cohn, Aaron A.R. Tobian |
| 107 |
[GO] |
2020―Sep―19 |
Convalescent Plasma Therapy in Patients with COVID-19 |
Fevzi Altuntas, Naim Ata, Tugce Nur Yigenoglu, Semih Bascı, Mehmet Sinan Dal, Serdal Korkmaz, Sinem Namdaroglu, Abdulkadir Basturk, Tuba Hacıbekiroglu, Mehmet Hilmi Dogu, İlhami Berber, Kursat Dal, Kerem Kınık, İbrahim Haznedaroglu, Fatma Meriç Yılmaz, İsa Kılıç, Sinan Demircioğlu, Alper Yosunkaya, Mehmet Ali Erkurt, Burhan Turgut, Murat Caglayan, Osman Celik |
| 108 |
[GO] |
2020―Sep―06 |
A consideration of convalescent plasma and plasma derivatives in the care of Severely-ill patients with COVID-19 |
Thomas Lung, Michel D. Kazatchkine, Lorenz Risch, Martin Risch, Urs E. Nydegger |
| 109 |
[GO] |
2020―Sep―06 |
Nurse’s perspective: The effects of Covid-19 in apheresis |
Lidia Yanchuk, Sue Sinclair, Sandy Pettman, Kari Lukianow |
| 110 |
[GO] |
2020―Sep―04 |
An Update on COVID-19 Infection Control Measures, Plasma-Based Therapeutics, Corticosteroid Pharmacotherapy and Vaccine Research |
Jeffrey S. Putter, Jerard Seghatchian |
| 111 |
[GO] |
2020―Sep―03 |
Update on newer approaches to prevent or treat COVID-19 infection: What we all need the most right now!! |
Jerard Seghatchian, Jason P. Acker, Jeffery S. Putter |
| 112 |
[GO] |
2020―Sep―01 |
Response Letter: Treatment for emerging viruses: Convalescent plasma and COVID-19 |
Bethany Brown |
| 113 |
[GO] |
2020―Aug―28 |
Anemia is associated with severe coronavirus disease 2019 (COVID-19) infection |
Timotius Ivan Hariyanto, Andree Kurniawan |
| 114 |
[GO] |
2020―Aug―27 |
Convalescent plasma for COVID-19 considerations |
Jeanne Adiwinata Pawitan |
| 115 |
[GO] |
2020―Aug―27 |
Convalescent Plasma as a Treatment Modality for Coronavirus Disease 2019 in Sudan |
Mozan Osman Hassan, Asma Ahmed Osman, Hana Elsir Abd Elbasit, Hanan Elsamani Hassan, Hala Rufai, Maria M.M. Satti, Musab Elnegoumi, Roaa Idris, Ashraf Musa, Abdelhakam H. Ali, Susan Ali Zroog, Amna Khairy, Mushal Allam, Asaad Tageldein Idris Abdelhalim |
| 116 |
[GO] |
2020―Aug―25 |
The successful management of an elderly Covid-19 infected patient by plasmapheresis |
Yasemin Akkoyunlu, Guven Cetin, Sibel Bolukcu, Gulay Okay, Hamza Ogun, Bulent Durdu, Fatmanur Okyaltirik, Kazim Karaslan |
| 117 |
[GO] |
2020―Aug―25 |
IMPACT OF COVID-19 PANDEMIC IN THE ACTIVITY OF A THERAPEUTIC APHERESIS UNIT IN ITALY |
A. Colpo, L. Astolfi, T. Tison, G. De Silvestro, P. Marson |
| 118 |
[GO] |
2020―Aug―25 |
SARS-CoV-2 Serology and Virology Trends in Donors and Recipients of Convalescent Plasma |
Latha Dulipsingh, Danyal Ibrahim, Ernst J. Schaefer, Rebecca Crowell, Margaret R. Diffenderfer, Kendra Williams, Colleen Lima, Jessica McKenzie, Lisa Cook, Jennifer Puff, Mary Onoroski, Dorothy B. Wakefield, Reginald J. Eadie, Steven B. Kleiboeker, Patricia Nabors, Syed A. Hussain |
| 119 |
[GO] |
2020―Aug―24 |
No transmission of SARS-CoV-2 in a patient undergoing allogeneic Hematopoietic Cell Transplantation from a matched-related donor with unknown COVID-19 |
P. Lázaro del Campo, A. Ramírez López, B. de la Cruz Benito, R. de Paz Arias, K. Humala Barbier, I. Sánchez Vadillo, A. López de la Guía, T. de Soto Álvarez, V. Jiménez Yuste, M. Canales Albendea |
| 120 |
[GO] |
2020―Aug―24 |
SEROPREVALENCE OF SARS-COV-2 ANTIBODIES AMONG HEALTHY BLOOD DONORS IN KARACHI, PAKISTAN |
Amber Younas, Samra Waheed, Shabnum Khawaja, Mehjabeen Imam, Munira Borhany, Tahir Shamsi |
| 121 |
[GO] |
2020―Aug―04 |
Intravenous Immunoglobulin and Favipiravir treatment for A Kidney Transplant Patient with Severe Covid-19 Pneumonia |
Erhan Tatar, Murat Karatas, Ilter Bozaci, Alpay Ari, Turker Acar, Cenk Simsek, Ali Murat Yildirim, Ozden Yildirim, Adam Uslu |
| 122 |
[GO] |
2020―Aug―03 |
Covid-19-induced coagulopathy and observed benefits with anticoagulation |
Sedighe Karimzade, Vinh Dong, Osama Gamal Hassan, Akshay Raut, Ahmed Fouda, Allison Parrill, Kimberly Eaton, Nguyen Tien Huy |
| 123 |
[GO] |
2020―Jul―16 |
Potential challenges faced by blood bank services during COVID-19 pandemic and their mitigative measures: The Indian scenario |
Priyadarsini J. Arcot, Karan Kumar, Tapasyapreeti Mukhopadhyay, Arulselvi Subramanian |
| 124 |
[GO] |
2020―Jul―15 |
Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study |
Hassan Abolghasemi, Peyman Eshghi, Abdol Majid Cheraghali, Abbas Ali Imani Fooladi, Farzaneh Bolouki Moghaddam, Sina Imanizadeh, Matin Moeini Maleki, Mohammad Ranjkesh, Mohammad Rezapour, Ali Bahramifar, Behzad Einollahi, Mohammad Javad Hosseini, Nematollah Joneidi Jafari, Mohamad Nikpouraghdam, Nariman Sadri, Mokhtar Tazik, Shanaz Sali, Shamsi Okati, Elham Askari, Payam Tabarsi, Jafar Aslani, Ehsan Sharifipour, Mohammad Hossein Jarahzadeh, Nastaran Khodakarim, Mahmood Salesi, Ramezan Jafari, Samira Shahverdi |
| 125 |
[GO] |
2020―Jul―15 |
Organization of the outdoor blood donation drives amid novel coronavirus pandemic and national lockdown: An experience from a tertiary care oncology institution in India |
Abhaykumar Malind Gupta, Shashank Ojha, Minal Poojary, Sumathi S.H., P. Nagaraju, Rajendra Dhokle |
| 126 |
[GO] |
2020―Jul―03 |
Prolonged Viral Shedding in a Lymphoma Patient with COVID-19 Infection Receiving Convalescent Plasma |
Ayşe Karataş, Ahmet Çağkan İnkaya, Haluk Demiroğlu, Salih Aksu, Tahmaz Haziyev, Olgu Erkin Çınar, Alpaslan Alp, Ömrüm Uzun, Nilgün Sayınalp, Hakan Göker |
| 127 |
[GO] |
2020―Jul―01 |
Challenges in platelet inventory management at a tertiary care oncology center during the novel coronavirus disease (COVID-19) pandemic lockdown in India |
Shashank Ojha, Abhaykumar Malind Gupta, P. Nagaraju, Poojary Minal, Sumathi S.H. |
| 128 |
[GO] |
2020―Jul―01 |
First case of convalescent plasma transfusion in a child with COVID-19-associated severe aplastic anemia |
Magdalena Figlerowicz, Anna Mania, Karol Lubarski, Zuzanna Lewandowska, Wojciech Służewski, Katarzyna Derwich, Jacek Wachowiak, Katarzyna Mazur-Melewska |
| 129 |
[GO] |
2020―Jun―27 |
Immunomodulation for the Management of Corona Virus Disease (COVID-19) |
Dobri Kiprov, Michael J. Conboy, Irina M. Conboy |
| 130 |
[GO] |
2020―Jun―27 |
Life-saving effect of convalescent plasma treatment in covid-19 disease: Clinical trial from eastern Anatolia |
Mehmet Ali Erkurt, Ahmet Sarici, İlhami Berber, İrfan Kuku, Emin Kaya, Mustafa Özgül |
| 131 |
[GO] |
2020―Jun―27 |
Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials? |
Olivier Garraud |
| 132 |
[GO] |
2020―Jun―26 |
Editorial: Information on the COVID-19 Pandemic continued. |
Gail Rock |
| 133 |
[GO] |
2020―Jun―25 |
Extracorporeal Blood Purification Treatment Options for COVID-19: The Role of Immunoadsorption |
Tuğçe Nur Yiğenoğlu, Turgay Ulas, Mehmet Sinan Dal, Serdal Korkmaz, Mehmet Ali Erkurt, Fevzi Altuntaş |
| 134 |
[GO] |
2020―Jun―04 |
Regulatory Consideration on Preparation and Clinical Use of COVID-19 Convalescent Plasma |
Yılmaz Soner, Ertuğrul Örüç Nigar, Azap Alpay, Özcebe Osman, Çetin Türker, Yenicesu İdil, Öztürk Abdullah, Gündüz Mehmet, Tekin Ahmet |
| 135 |
[GO] |
2020―Jun―04 |
Management of blood supply and demand during the COVID-19 pandemic in King Abdullah Hospital, Bisha, Saudi Arabia |
Amar Ibrahim Omer Yahia |
| 136 |
[GO] |
2020―Jun―03 |
COVID-19 and the ABO blood group connection |
Fatima Zia Zaidi, Abdul Rehman Zia Zaidi, Syed Maaz Abdullah, Syed Ziauddin Ahmed Zaidi |
| 137 |
[GO] |
2020―Jun―03 |
Current treatment approaches for COVID-19 and the clinical value of transfusion-related technologies |
Ying Li, Shanglong Liu, Shuchao Zhang, Qiang Ju, Shaoqiang Zhang, Yuanming Yang, Haiyan Wang |
| 138 |
[GO] |
2020―May―29 |
Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis |
Olgu Erkin Çınar, Başak Sayınalp, Elifcan Aladağ Karakulak, Ayşe Avşar Karataş, Mustafa Velet, Ahmet Çağkan İnkaya, Nazmiye Ebru Ersoy Ortaç, Serpil Öcal, Salih Aksu, İbrahim Celalettin Haznedaroğlu, Nilgün Sayınalp, Osman İlhami Özcebe |
| 139 |
[GO] |
2020―May―21 |
Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19 |
Accorsi Patrizia, Berti Pierluigi, de Angelis Vincenzo, De Silvestro Giustina, Mascaretti Luca, Ostuni Angelo |
| 140 |
[GO] |
2020―May―21 |
Dwindling blood reserves: An ominous downside of COVID-19 pandemic |
Sohail Kumar, Dua Azim, Sundus Nasim, Shariq Haider Hashmi |
| 141 |
[GO] |
2020―May―21 |
Successful treatment of a centenarian with coronavirus disease 2019 (COVID-19) using convalescent plasma |
Yujie Kong, Chen Cai, Li Ling, Li Zeng, Meihong Wu, Yanyun Wu, Wei Zhang, Zhong Liu |
| 142 |
[GO] |
2020―May―04 |
Covid-19, induced activation of hemostasis, and immune reactions: Can an auto-immune reaction contribute to the delayed severe complications observed in some patients? |
Jean Amiral, Anne Marie Vissac, Jerard Seghatchian |
| 143 |
[GO] |
2020―Apr―23 |
Theme: information on the Covid-19 Pandemic |
Gail Rock |
| 144 |
[GO] |
2020―Apr―21 |
TreaTment for emerging viruses: Convalescent plasma and COVID-19 |
Bethany L. Brown, Jeffrey McCullough |
| 145 |
[GO] |
2020―Apr―21 |
COVID-19: A Perspective of a Frontline Worker |
Emy Cowlan |
